Friday, July 10, 2026
🇺🇸 FDA

Drug profile · INN

taxanes

taxanes is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 2
Pipeline programs 2
News articles 0
Drug details — taxanes
Class
—
Route
—
Patents
2
Programs
2
Data quality
0.70
← All drugs Related patents Pipeline programs Drug news hub Event calendar

Quick answer

taxanes is an FDA-listed pharmaceutical active ingredient.

Key facts

INN taxanes

Approval history

Authority Status Date
NMPA clinical trials —

Pipeline programs

Browse pipeline
  1. 2023/3668 Phase 2 · George Institute for · Patients with HER2-positive (HER2-pos) (cohort 1) or HER2-lo
  2. TAR-0520 Gel Phase 2 · Anaxis Pharma · Taxanes-induced peripheral neuropathy

Related patents

Browse patents

  1. US 11896558

    Use of an RXR agonist and taxanes in treating Her2+ cancers

    Expires Mon Feb 08 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 9199954

    Non-ring hydroxy substituted taxanes and methods for synthesizing the same

    Expires Mon Nov 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is taxanes?

taxanes is an FDA-listed pharmaceutical active ingredient.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.